Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial
Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial
Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial
Submitted by
admin
on August 20, 2015 - 8:26am
Source:
Yahoo/Reuters
News Tags:
Eli Lilly
Boehringer Ingelheim
Jardiance
Headline:
Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial
Do Not Allow Advertisers to Use My Personal information
